Suspension of trading

Valuation Checkpoint Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 30/05/2025 +04			5-day change	1st Jan Change
4.260 ^USD	+0.71%		-.--%	-

02/06/25	Checkpoint Therapeutics, Inc.(NasdaqCM:CKPT) dropped from S&P TMI Index	CI
30/05/25	Sun Pharmaceutical Industries Limited completed the acquisition of Checkpoint Therapeutics, Inc. from Fortress Biotech, Inc., Armistice Capital Master Fund Ltd., managed by Armistice Capital LLC and others.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024
Market Cap ¹	88.79	179.9	260.5	52.39	53.87	156.3
Change	-	102.61%	44.83%	-79.89%	2.84%	190.05%
Enterprise Value (EV) ¹	62.71	139.1	205.8	40.32	48.95	149.7
Change	-	121.85%	47.93%	-80.41%	21.4%	205.76%
P/E	-2.46x	-6.41x	-4.64x	-0.84x	-1.23x	-2.26x
PBR	4.93x	5.2x	8.84x	-2.7x	-4.87x	-13.8x
PEG	-	0.2x	-0.1x	0.09x	0x	0.1x
Capitalization / Revenue	52x	168x	972x	273x	523x	3,811x
EV / Revenue	36.7x	130x	768x	210x	475x	3,650x
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-2.52x	-6x	-3.63x	-0.69x	-0.94x	-2.66x
EV / FCF	-4.08x	-10.3x	-16.2x	-1.49x	-1.13x	-8.05x
FCF Yield	-24.5%	-9.75%	-6.18%	-66.9%	-88.4%	-12.4%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-7	-4.134	-6.701	-6.088	-1.869	-1.418
Distribution rate	-	-	-	-	-	-
Net sales ¹	1.708	1.069	0.268	0.192	0.103	0.041
EBITDA	-	-	-	-	-	-
EBIT ¹	-24.85	-23.2	-56.72	-58.33	-52.15	-56.17
Net income ¹	-24.71	-23.08	-56.67	-62.62	-51.85	-56.24
Net Debt ¹	-26.08	-40.77	-54.74	-12.07	-4.928	-6.604
Reference price ²	17.200	26.500	31.100	5.110	2.290	3.200
Nbr of stocks (in thousands)	5,162	6,788	8,377	10,252	23,526	48,833
Announcement Date	11/03/20	12/03/21	28/03/22	31/03/23	22/03/24	28/03/25

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHECKPOINT THERAPEUTICS, INC.	-	-	-	-	357M
WUXI APPTEC CO., LTD.	20.78x	7.37x	14.79x	1.43%	70.88B
ARGENX SE	32.47x	9.38x	45.35x	0.04%	62.49B
INSMED INCORPORATED	-73.25x	14.16x	-68.28x	-.--%	26.21B
WUXI BIOLOGICS (CAYMAN) INC.	30.44x	6.47x	16.8x	-.--%	26.34B
BIONTECH SE	-14.7x	5.35x	-6.73x	-.--%	24.13B
GENMAB A/S	28.25x	5.33x	17.72x	-.--%	20.72B
PHARMAESSENTIA CORPORATION	44.51x	16.33x	33.12x	0.34%	15.36B
EXELIXIS, INC.	18.03x	5.37x	12.55x	-.--%	14.46B
SUMMIT THERAPEUTICS INC.	-15.41x	3483.86x	-17.81x	-.--%	14.25B
Average	7.90x	394.85x	5.28x	0.2%	27.52B
Weighted average by Cap.	12.15x	188.68x	11.56x	0.4%